We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Molecular Tests Detect Colorectal and Prostate Cancer

By Labmedica staff writers
Posted on 09 Jun 2008
Print article
Colorectal cancer lymph node micrometastasis was detected using the guanylyl cyclase C (GCC) marker, and prostate cancer using the PCA3 marker.

GCC is expressed only in intestinal mucosal cells, but not in extra-intestinal tissues. In addition, GCC is expressed in colorectal tumors, but not in other cancers outside the gastrointestinal tract. Therefore, GCC may be useful clinically for the management of patients with colorectal cancer in providing information that is more accurate to physicians and patients and influencing treatment decisions.

A DiagnoCure (Québec, Canada) product, the Previstage GCC test was studied in 1,500 lymph nodes. The study demonstrated that in patients previously staged as having no positive lymph nodes (stage II), 30 % had at least one lymph node with GCC expression at least as high as that found in lymph nodes called positive by a pathologist (stage III). This would indicate that these patients should be considered for cancer management equal to that for a stage III patient.

The PCA3-based test, also developed by DiagnoCure, was used as a biomarker for prostate-cancer disease stratification.

The two DiagnoCure products, the PCA3 marker for prostate cancer and Previstage GCC for the staging of colorectal cancer, were presented at scientific meetings as part of the growing trend to molecular diagnostics. On June 4, 2008, DiagnoCure opened the sessions at the 34th annual International Clinical Ligand Assay Society Meeting held in Coral Springs (FL, USA), with a presentation on its guanylyl cyclase C (GCC) testing study.

At the meeting of the American Urological Association (AUA) in Orlando (FL,USA), which ended on June 4, 2008, the PCA3 marker-based test was the subject of several presentations and three exhibits. Gen-Probe, Inc. (San Diego, CA, USA), DiagnoCure's commercialization partner for PCA3, and other versions of the test by several different companies were also presented at the meeting.


Related Links:
DiagnoCure
Gen-Probe
New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Unit-Dose Packaging solution
HLX
New
Cooling Table Centrifuge
MPW-352R
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.